Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Benh
    Member
    • Aug 2012
    • 11

    #1

    TPM vs RPKM

    Hello SeqAns community,

    This may be a naive question, but after reading the paper from Wagner, 2012 and watched the video from Lior, I still don't see the benefit of switching from R/FPKM to TPM.

    From my understanding:
    - TPM and RPKM are both relative abundance units
    - Both are acceptable units when comparing genes from the same sample, but being relative quantity, it is not appropriate to compare TPM/RPKM values from different samples directly. Some (further) normalization is needed.
    - In Wagner's paper it was mentioned that avg TPM is consistent (like relative molar concentration) while avg RPKM is not. What is the significant of this?

    Thank you!
  • crazyhottommy
    Senior Member
    • Apr 2012
    • 187

    #2
    see here Paper: RPKM measure is inconsistent among samples http://www.ncbi.nlm.nih.gov/pubmed/?term=22872506
    and here http://blog.nextgenetics.net/?e=51

    Comment

    • Brian Bushnell
      Super Moderator
      • Jan 2014
      • 2709

      #3
      From glancing at the paper, it looks like the difference is that FPKM normalizes by relative mass (or number of nucleotides) while TPM normalizes by relative molarity (or number of transcripts). I don't really see why one is inherently better than the other, but it would make a difference in some cases.

      Suppose you have an organism with 3 genes, A, B, and C, such that A is your gene of interest; B is some random short gene and C is some random long gene. You have 2 samples with exactly 1 molar A (in other words, no expression change). Sample 1 has 1 molar B and 0 molar C. Sample 2 has 0 molar B and 1 molar C.

      Because C is longer than B, each transcript will generate more fragments. So sample 2 will have a lower FPKM of A than sample 1, even though the molarity of A did not change. Therefore FPKM is not an ideal measure of relative molarity.

      However, from a cell's perspective, it doesn't really allocate a certain molarity of different transcripts; rather, it has a finite amount of nucleotides from which it can construct RNA. Furthermore, it has a finite amount of amino acids from which it can construct proteins. So I suspect that transcripts of different genes don't really compete with each other on a relative molarity scale, but on a relative mass scale - the amount of protein generated from some gene should depend on the fraction of nucleotides representing that gene, not the relative molarity. And therefore, to measure effective expression, FPKM should be a better metric.

      Thus, in summary, it seems to me that the premise of the paper is basically wrong.

      Comment

      • Benh
        Member
        • Aug 2012
        • 11

        #4
        Originally posted by crazyhottommy View Post
        see here Paper: RPKM measure is inconsistent among samples http://www.ncbi.nlm.nih.gov/pubmed/?term=22872506
        and here http://blog.nextgenetics.net/?e=51
        Thank you for your response Tommy.

        Indeed I have read both articles (actually it's the same paper that I posted), but it seems to me that there is no clear benefit why TPM is better... Simply because the avg_TPM is consistent with avg_rmc?

        On a practical level, RPKM, just like TPM, works for comparing genes expressed within the same sample. Meanwhile, neither units are directly suitable for direct comparison (for differential expression anyways)... so nothing's changed here except for the choice of tool .... Please correct me if I'm wrong.

        Wonder if anyone noticed anything different with their calculations (e.g. fold change..etc) when different units are used.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...